183 related articles for article (PubMed ID: 7693955)
1. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
[TBL] [Abstract][Full Text] [Related]
2. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.
Motzer RJ; Gulati SC; Crown JP; Weisen S; Doherty M; Herr H; Fair W; Sheinfeld J; Sogani P; Russo P
Cancer; 1992 Jan; 69(2):550-6. PubMed ID: 1309436
[TBL] [Abstract][Full Text] [Related]
4. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.
Neidhart JA; Kohler W; Stidley C; Mangalik A; Plauche A; Anderson T; Quenzer RW; Rinehart JJ
J Clin Oncol; 1990 Oct; 8(10):1728-38. PubMed ID: 2213108
[TBL] [Abstract][Full Text] [Related]
6. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.
Nichols CR; Andersen J; Lazarus HM; Fisher H; Greer J; Stadtmauer EA; Loehrer PJ; Trump DL
J Clin Oncol; 1992 Apr; 10(4):558-63. PubMed ID: 1312584
[TBL] [Abstract][Full Text] [Related]
7. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
Motzer RJ; Geller NL; Bosl GJ
Cancer; 1990 Sep; 66(5):857-61. PubMed ID: 1696846
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
[TBL] [Abstract][Full Text] [Related]
9. Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
Wilson WH; Jain V; Bryant G; Cowan KH; Carter C; Cottler-Fox M; Goldspiel B; Steinberg SM; Longo DL; Wittes RE
J Clin Oncol; 1992 Nov; 10(11):1712-22. PubMed ID: 1403054
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
11. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
12. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
Santana VM; Schell MJ; Williams R; Bowman LC; Thompson EI; Brenner MK; Mirro J
Bone Marrow Transplant; 1992 Nov; 10(5):457-62. PubMed ID: 1464010
[TBL] [Abstract][Full Text] [Related]
13. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Motzer RJ; Geller NL; Tan CC; Herr H; Morse M; Fair W; Sheinfeld J; Sogani P; Russo P; Bosl GJ
Cancer; 1991 Mar; 67(5):1305-10. PubMed ID: 1703917
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
15. Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors.
Broun ER; Nichols CR; Einhorn LH; Tricot GJ
Cancer; 1991 Oct; 68(7):1513-5. PubMed ID: 1654195
[TBL] [Abstract][Full Text] [Related]
16. [High dose chemotherapy and autologous bone marrow transplantation for advanced germ cell tumor].
Ishii H; Osa Y; Okano T; Isaka S; Yasuda K; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1473-9. PubMed ID: 2177125
[TBL] [Abstract][Full Text] [Related]
17. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
Kretschmar C; Kleinberg L; Greenberg M; Burger P; Holmes E; Wharam M
Pediatr Blood Cancer; 2007 Mar; 48(3):285-91. PubMed ID: 16598761
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of high-dose etoposide, high-dose cisplatin, and reinfusion of autologous bone marrow for lung cancer.
Lazarus HM; Spitzer TR; Creger RJ
Am J Clin Oncol; 1990 Apr; 13(2):107-12. PubMed ID: 2156415
[TBL] [Abstract][Full Text] [Related]
19. High dose chemotherapy including vepeside, cyclophosphamide and carboplatin with autologous bone marrow transplantation in one case of chemoresistant testicular cancer.
Colombat P; Linassier C; Binet C; Desbois I; Chazard M; Reisenleiter M; Haillot O; Lamagnere JP
Biomed Pharmacother; 1989; 43(6):455-6. PubMed ID: 2686773
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Motzer RJ; Cooper K; Geller NL; Pfister DG; Lin SY; Bajorin D; Scher HI; Herr H; Fair W; Morse M
Cancer; 1990 Jun; 65(11):2465-70. PubMed ID: 1692505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
